2m 2m 2m 2m 2m 2m 2m
SERINA THERAP (SER)
NYSE
$1.76+$0.0010 (+0.06%)
Price as of Oct 23, 2026 4:00 AM EDT- $44.7MMarket Cap
- -65.92%1-Year Change
- BiotechnologyIndustry
SERINA THERAP (SER)
$1.76+$0.0010 (+0.06%)
SER | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.76 | ||
Change | -$0.01 (-0.56%) | ||
Open | $1.73 | ||
High | $1.80 | ||
Low | $1.72 | ||
Previous Close | $1.77 | ||
Volume | 51,258 | ||
30-Day Average Volume | 77,292 | ||
1-Week Change | -1.68% | ||
1-Month Change | -23.81% | ||
1-Year Change | -65.92% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 25.4M | ||
Total Assets | $25.8M | ||
Market Cap | $44.7M | ||
Enterprise Value | $24.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.4M | ||
Free Cash Flow | -$6.7M | ||
EBIT | -$6.4M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $21.3M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -3 | ||
PEG | -1 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue